Tri Locum Partners’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,009
Closed -$19K 72
2022
Q4
$19K Buy
+10,009
New +$19K 0.01% 58